Dsicover a recent study that compared Stockholm3 with other established biomarkers for prostate cancer screening. Learn more.

A new study provides the strongest evidence to date on the clinical utility of a polygenic score for prostate cancer ...

“This test could turn the tide on prostate cancer,” said Prof. Ros Eeles, who led the study. “We have shown that a relatively ...

A new spit test for prostate ... a polygenic risk score, which uses spit to assess 130 genetic variants known to be associated with an increased risk of prostate cancer, which can then determine ...

A new at-home spit test for ... a polygenic risk score. This risk score uses spit to assess 130 genetic variants known to be associated with an increased risk of prostate cancer.

The saliva test analyses 130 genetic variants to calculate a polygenic risk score (PRS), identifying individuals at higher risk for prostate cancer. The study was conducted by the Institute of ...

The test developed at the Institute for Cancer Research provides men with a polygenic risk score on the bases of 130 gene variants known to be associated with in increased chance of prostate cancer. A ...

A new at-home saliva test for ... a polygenic risk score. This risk score uses spit to assess 130 genetic variants known to be associated with an increased risk of prostate cancer.

Researchers have developed a simple spit test ... risk score. This risk score uses spit to assess 130 genetic variants known to be associated with an increased risk of prostate cancer and then ...

For the men with the highest risk score, the study found this to be a better tool than the blood test which measures levels of a protein called prostate-specific antigen (PSA), which can be elevated ...

Further tests revealed that I had prostate cancer, and I was told that a relatively low PSA score can still be harbouring a life-threatening tumour if the person falls in a certain genetic group.

Don't miss out on the headlines from Cancer. Followed categories will be added to My News. The test ... associated with prostate cancer in order to develop a polygenic risk score.